期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 26, 期 18, 页码 2126-2137出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v26.i18.2126
关键词
Annexin A2; Hepatocellular carcinoma; Immune microenvironment; Overall survival; Chemotherapy resistance; Checkpoint
资金
- National Natural Science Foundation of China [81401988]
- China Postdoctoral Science Foundation [2019M661907]
- Jiangsu Postdoctoral Science Foundation [2019K159, 2019Z153]
- General Project of Jiangsu Provincial Health Committee [H2019101]
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a dismal prognosis, especially when diagnosed at advanced stages. Annexin A2 (ANXA2), is found to promote cancer progression and therapeutic resistance. However, the underlining mechanisms of ANXA2 in immune escape of HCC remain poorly understood up to now. Herein, we summarized the molecular function of ANXA2 in HCC and its relationship with prognosis. Furthermore, we tentatively elucidated the underlying mechanism of ANXA2 immune escape of HCC by upregulating the proportion of regulatory T cells and the expression of several inhibitory molecules, and by downregulating the proportion of natural killer cells and dendritic cells and the expression of several inhibitory molecules or effector molecules. We expect a lot of in-depth studies to further reveal the underlying mechanism of ANXA2 in immune escape of HCC in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据